2024-08-05 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.24 | $256,357 | -4.03% | |
2024-08-02 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.29 | $216,400 | -7.03% | |
2024-07-31 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.33 | $132,640 | -0.48% | |
2024-07-30 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.30 | $226,370 | +1.3% | |
2024-07-30 | Purchase | Adverum Biotechnologies, Inc. ADVM | 10 percent owner | | $7.15 | $613,470 | +5.87% | |
2024-07-22 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.33 | $23,557 | -10.53% | |
2024-07-19 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.30 | $8,696 | -9.85% | |
2024-07-18 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.30 | $169,555 | -9.16% | |
2024-07-18 | Purchase | Adverum Biotechnologies, Inc. ADVM | 10 percent owner | | $9.11 | $735,737 | -23% | |
2024-07-17 | Purchase | Adverum Biotechnologies, Inc. ADVM | 10 percent owner | | $7.75 | $1.05M | -16.86% | |
2024-07-05 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.15 | $141,334 | 0% | |
2024-07-03 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.16 | $166,071 | 0% | |
2024-07-02 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.14 | $98,489 | 0% | |
2024-07-01 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.14 | $122,185 | 0% | |
2024-06-28 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.12 | $1.35M | 0% | |
2024-06-27 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.15 | $271,331 | 0% | |
2024-06-18 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.13 | $56,505 | +5.31% | |
2024-06-17 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.13 | $169,500 | +5.31% | |
2024-06-14 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.17 | $402,201 | +0.85% | |
2024-06-13 | Purchase | Aclaris Therapeutics, Inc. ACRS | 10 percent owner | | $1.15 | $607,757 | 0% | |